Gland Pharma Limited — Others, 21-05-2025: Copy of Newspaper Publication

Gland Pharma has announced a board meeting to approve the financial results for the quarter and half-year. The audited consolidated and standalone results, certified by Deloitte Haskins & Sells, are now available on the company’s website and stock exchange portals. This timely disclosure reinforces transparency, offering shareholders verified performance insights to support informed investment decisions.